Background Multiple sclerosis (MS) is an immune‐mediated disease of the central nervous
system affecting an estimated 1.3 million people worldwide. It is characterised by a variety of …

Background Exercise training may affect the blood levels of brain-derived neurotrophic
factor (BDNF), but meta-analyses have not yet been performed comparing pre-and post …

Background Altered thalamic volumes and resting state (RS) functional connectivity (FC)
might be associated with physical activity (PA) and cardiorespiratory fitness (CRF) in people …

Multiple sclerosis (MS) is an immune-mediated disorder of the central nervous system (CNS)
characterized by chronic inflammation and neurodegeneration, impacting approximately 2.8 …

Background: Progressive forms of multiple sclerosis (MS) affect more than 1 million
individuals globally. Recent approvals of ocrelizumab for primary progressive MS and …

Background The COVID-19 pandemic has likely had a negative impact on rehabilitation and
quality of life (QoL) research in multiple sclerosis (MS). Method We explored perceived …

Introduction Fatigue is one of the most common and debilitating symptoms of multiple
sclerosis (MS) but is challenging to assess and has not been comprehensively …

Pandemic restrictions have led to changes in therapy plans and disrupted rehabilitation
services for people with multiple sclerosis. CogEx is an international, multicentre MS dual …

Background Differences in pain between subtypes of multiple sclerosis are understudied.
Objective To compare the prevalence of pain, and the association between pain and:(a) …

Background Cognitive dysfunction in people with relapsing-remitting multiple sclerosis can
improve with cognitive rehabilitation or exercise. Similar effects have not been clearly shown …